Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amylx Pharmaceuticals Inc (AMLX) vs Eli Lilly And Co (LLY) Price & Performance

Amylx Pharmaceuticals IncTrade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs Eli Lilly And Co — how do they compare? Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.53B), while Eli Lilly And Co trades at $1,213.06 (market cap $1.10T). The key difference: Eli Lilly And Co is far larger — about 434.8× Amylx Pharmaceuticals Inc's market cap, and Eli Lilly And Co pays a 0.56% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

AMLXLLY
Market Cap
$2.53B$1.10T
Sector
HealthHealth
52-Week High
$24.19$1.24K
52-Week Low
$7.82$639.43
Enterprise Value
$2.28B$1.14T
Dividend Yield
0.56%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Amylx Pharmaceuticals Inc

AMLX trades at $22.82, down 5.66% on the day, with a bullish technical signal from moving averages and key support at $22. The company reported a net loss of -$144.74M for 2025, with negative ROE and ROA, but holds a $250.8M cash runway into 2028. The pivotal Phase 3 LUCIDITY trial for avexitide is set for a late August/early September 2026 readout, a key near-term catalyst.

Analyst consensus is strongly bullish with a $30.00 price target, though recent earnings misses and negative cash flow from operations in 2026 pose risks. The stock's outlook hinges on successful clinical trial results and the subsequent regulatory pathway for its lead endocrine asset.

Eli Lilly And Co

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY